Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Discover effective ways to accelerate your credit card points earning. Maximize your rewards with smart strategies.
20,345 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
DHT Holdings has benefited from surging tanker rates and a policy of distributing all ordinary net income as dividend...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
The Nasdaq Composite steadied amid a breathless week of data, with investors weighing slowing growth against resilien...
Markets are being shaped by two persistent trends as 2026 unfolds. This report explains how investors can act to take...
A trio of midstream dividend ETFs yielding more than 5% are delivering market-beating performance, offering both inco...
Coinbase faces a volatile crypto backdrop, but a broader push into institutional services and fintech partnerships co...
Three leading tech ETFs battle for AI-era glory. This story breaks down Nvidia exposure, valuation, and risk to answe...
HUD agencies are weighing the next steps for HECM and HMBS after an extended public-comment period, with lenders urgi...
The Terraform Estate has filed a lawsuit in New York against Jane Street, alleging the trading firm profited from pri...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...